Miromatrix Medical Inc.
MIRODelisted Dec 13, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001527096
Miromatrix Medical Inc. was delisted on Dec 13, 2023; its insiders filed their last Form 4 on Dec 13, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $8.78M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Miromatrix Medical Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q1 2022
- Shares held
- 3.24M
- +63.3K (+2.0%) vs. Q1 2022
- Total value
- $12.9M
- +$348.0K (+2.8%) vs. Q1 2022
- New holders
- 3
- 7 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 32 | $8.78M |
| Q2 2023 | 32 | $11.6M |
| Q1 2023 | 31 | $11.1M |
| Q4 2022 | 28 | $11.2M |
| Q3 2022 | 22 | $15.4M |
| Q2 2022 | 22 | $12.9M |
| Q1 2022 | 21 | $12.6M |
| Q4 2021 | 22 | $14.5M |
| Q3 2021 | 19 | $22.0M |
| Q2 2021 | 21 | $39.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Miromatrix Medical Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 45 | $0 | 0.00% | +4+9.8% | Added |
| Advisor Group Holdings, Inc. | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,000 | $4.00K | 0.00% | −507−33.6% | Reduced |
| UBS Group AG | 1,793 | $7.00K | 0.00% | −462−20.5% | Reduced |
| Royal Bank of Canada | 2,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 10,000 | $40.0K | 0.00% | 00.0% | Unchanged |
| Ulland Investment Advisors, LLC | 12,000 | $48.0K | 0.05% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 13,536 | $54.0K | 0.00% | +13,536 | New |
| Legacy Wealth Asset Management, LLC | 13,536 | $54.0K | 0.02% | +13,536 | New |
| Perkins Capital Management Inc | 21,880 | $87.0K | 0.09% | 00.0% | Unchanged |
| State Street Corp | 24,217 | $97.0K | 0.00% | +800+3.4% | Added |
| Commonwealth Equity Services, LLC | 26,669 | $106.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 35,078 | $140.0K | 0.00% | +4,939+16.4% | Added |
| Geode Capital Management, LLC | 47,089 | $187.0K | 0.00% | +25,419+117.3% | Added |
| Cambridge Investment Research Advisors, Inc. | 66,900 | $267.0K | 0.00% | −1,500−2.2% | Reduced |
| Sweet Financial Partners, LLC | 104,167 | $416.0K | 0.13% | +104,167 | New |
| Vanguard Group Inc | 172,547 | $689.0K | 0.00% | +2,681+1.6% | Added |
| RTW Investments, LP | 280,000 | $1.12M | 0.03% | 00.0% | Unchanged |
| Gagnon Advisors, LLC | 459,604 | $1.83M | 1.11% | 00.0% | Unchanged |
| First Light Asset Management, LLC | 516,007 | $2.06M | 0.24% | +3,700+0.7% | Added |
| G2 Investment Partners Management LLC | 539,511 | $2.15M | 0.69% | −53,793−9.1% | Reduced |
| Gagnon Securities LLC | 891,325 | $3.56M | 0.75% | +42,212+5.0% | Added |
| Stillwater Investment Management, LLC | 0 | $0 | 0.00% | −90,146−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,288−100.0% | Sold out |